Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cross Country Healthcare (CCRN) Depreciation & Amortization - Total (2016)

Historic Depreciation & Amortization - Total for Cross Country Healthcare (CCRN) over the last 7 years, with Q4 2016 value amounting to $1.1 million.

  • Cross Country Healthcare's Depreciation & Amortization - Total rose 1624.74% to $1.1 million in Q4 2016 from the same period last year, while for Sep 2017 it was $1.1 million, marking a year-over-year decrease of 7236.48%. This contributed to the annual value of $4.2 million for FY2016, which is 809.13% up from last year.
  • Per Cross Country Healthcare's latest filing, its Depreciation & Amortization - Total stood at $1.1 million for Q4 2016, which was up 1624.74% from $995000.0 recorded in Q3 2016.
  • In the past 5 years, Cross Country Healthcare's Depreciation & Amortization - Total ranged from a high of $1.4 million in Q1 2012 and a low of $817000.0 during Q2 2014
  • Moreover, its 5-year median value for Depreciation & Amortization - Total was $1.0 million (2014), whereas its average is $1.0 million.
  • Over the last 5 years, Cross Country Healthcare's Depreciation & Amortization - Total had its largest YoY gain of 4339.34% in 2012, and its largest YoY loss of 3313.95% in 2012.
  • Cross Country Healthcare's Depreciation & Amortization - Total (Quarter) stood at $1.1 million in 2012, then fell by 15.63% to $934000.0 in 2013, then rose by 14.56% to $1.1 million in 2014, then fell by 10.84% to $954000.0 in 2015, then grew by 16.25% to $1.1 million in 2016.
  • Its last three reported values are $1.1 million in Q4 2016, $995000.0 for Q3 2016, and $1.1 million during Q2 2016.